Galveston, TX, United States of America

Harshini Neelakantan


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Harshini Neelakantan: Innovator in Small Molecule Inhibitors

Introduction

Harshini Neelakantan is a prominent inventor based in Galveston, Texas. She has made significant contributions to the field of medicinal chemistry, particularly in the development of small molecule inhibitors. With a total of two patents to her name, her work focuses on innovative solutions that have the potential to impact therapeutic applications.

Latest Patents

Neelakantan's latest patents include "Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof." This invention relates to the preparation and application of quinoline-derived small molecule inhibitors targeting NNMT. The patent outlines the structure and potential uses of these inhibitors, which could play a crucial role in various therapeutic contexts.

Career Highlights

Harshini Neelakantan is affiliated with the University of Texas System, where she continues to advance her research in medicinal chemistry. Her academic background and ongoing research contribute to her reputation as an innovative thinker in her field.

Collaborations

Throughout her career, Neelakantan has collaborated with esteemed colleagues such as Stanley J. Watowich and Hua-Yu Wang. These partnerships have fostered a collaborative environment that enhances the research and development of her inventions.

Conclusion

Harshini Neelakantan is a trailblazer in the field of small molecule inhibitors, with her innovative patents paving the way for future advancements in medicinal chemistry. Her contributions to the University of Texas System and collaborations with fellow researchers highlight her commitment to scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…